Navigation Links
Two New Studies Report Increased Survival Rates in Tamiflu(R)-Treated Patients with Avian Flu (H5N1) and Severe Seasonal Flu
Date:9/13/2009

SAN FRANCISCO, Sept. 13 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that two new observational studies concluded that influenza patients treated with Tamiflu(R) (oseltamivir phosphate) had significantly higher survival rates than untreated patients. The studies, examining nearly 1,000 people, analyzed outcomes for two different groups -adults and children diagnosed with the highly pathogenic A (H5N1) avian influenza and adults hospitalized with seasonal influenza. Results, which build on similar findings(i), were presented today at the 49th ICAAC annual meeting in San Francisco.(ii,iii)

"These retrospective studies support the potential benefits of antiviral treatment in severe cases of influenza," said Dominick Iacuzio, Ph.D., medical director at Roche, which manufactures Tamiflu. "While Tamiflu is approved and used in many countries to treat and prevent all types of A and B influenza, these 'real-world' studies contribute to the body of clinical evidence."

Study Summaries

First Results from an Avian Influenza Case Registry (Presentation V-533) -- Sunday, September 13, 2009, 9:00 a.m. - 9:30 a.m. PT, Marriott Salon 9.

The study examined outcomes data for 215 patients from 10 countries who were diagnosed with the virulent A (H5N1) avian influenza. The retrospective observational study found that untreated patients had a mortality rate of 88%, with 11 out of 89 (12%) untreated patients surviving, in contrast to survival of 45 out of 85 (53%) patients who received at least one dose of Tamiflu up to 8 days after symptom onset. Among a subset of patients who received Tamiflu within 2 days of symptom onset, 5 out of 7 patients (71%) survived.

The study was conducted by researchers from Avex Avian Influenza Expert Group and the London School of Hygiene and Tropical Medicine, in collaboration with R
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
2. Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations
3. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
4. Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss
5. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
6. PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies
7. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
8. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
9. School of Dentistry Studies Link Between Oral Health and Memory
10. Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
11. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers and Energy ... data on the Spain Aesthetic Lasers and Energy ... of US dollars, volume (in units) and average ... Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG ... Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- On September 8, 2014, Dr. ... a Citizen Petition to Dr. Margaret Hamburg ... another Black Box Warning to Levaquin, Cipro, and ... a Black Box Warning for the following psychiatric ... or acts, loss of consciousness, delirium, depressed level ...
(Date:9/15/2014)... BRUSSELS , Sept. 15, 2014 ... Brussels:UCB) today announced results from several exploratory analyses of ... with low bone mineral density (BMD). Romosozumab is an ... inhibiting the protein sclerostin, thereby increasing bone formation and ... American Society for Bone and Mineral Research (ASBMR) 2014 ...
Breaking Medicine Technology:Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 2New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 4New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 5New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 6New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 7New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 8New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 9New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 10New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 11New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 12New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 13New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 14New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 15
(Date:9/16/2014)... Triad Semiconductor, Inc. today announced that David ... former President of Linear Technology Corporation was appointed to ... technology and business expertise, and we are delighted that ... Hayden, Triad CEO and chairman. , Mr. Bell brings ... semiconductor experience to Triad's board. From 2008 to 2012, ...
(Date:9/16/2014)... The Fertility Centers of New England is ... The collaboration will give patients access to high-quality frozen ... the Fertility Centers of New England. , Fairfax Egg ... largest selection of frozen donor eggs. Access to frozen ... , The Donor is already screened and her ...
(Date:9/16/2014)... BamboofloorChina.com, a famous online supplier of bamboo products, has ... bamboo panels . The firm is now offering big ... high quality items. Please note that the big sale ... , According to the company’s chief executive officer, ... visit BamboofloorChina.com before September 28. BamboofloorChina.com is offering more ...
(Date:9/15/2014)... September 16, 2014 With the variety ... is difficult to know the details on each one. ... the potential substances falling into their teen’s hands. ... marijuana itself among high school students. With varied, misleading ... and elsewhere, it can be difficult for parents to ...
(Date:9/15/2014)... Hastings and Hastings, an experienced and established ... flat attorney fee for personal injury cases. The firm ... portion possible of their settlement or recovery as a ... personal property. In addition, Hastings and Hastings makes an ... that no fees are due unless a settlement or ...
Breaking Medicine News(10 mins):Health News:David Bell Joins Triad Semiconductor's Board of Directors 2Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Cheap Bamboo Panels Unveiled By Famous Online Supplier BamboofloorChina.com 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 2Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 3
... is a potentially debilitating childhood disease. Early detection ... term joint damage and disability. Research has shown ... assessments in joint activity and sub-clinical disease, according ... Roentgen Ray Society,s annual meeting. The study, performed ...
... HealthDay Reporter , WEDNESDAY, May 4 (HealthDay News) -- ... prescribed inhaled steroids, British researchers found that the oral ... The oral medications, known as leukotriene-receptor antagonists, "have shown ... be considered for any patient, not as a last ...
... May 4 (HealthDay News) -- A gene essential to cardiac ... defects that cause a major proportion of childhood death from ... defects -- all malformations of the left ventricular outflow tract ... may play a role. "It is estimated that there ...
... LOUIS and DES MOINES, Iowa, May 4, 2011 The ... $4 million grant from the Howard G. Buffett Foundation to ... The grant will help fund the completion of the development ... Africans who depend upon sorghum as their staple diet. ...
... for cancer during childhood have an increased risk ... according to a new study in Gastroenterology ... Association (AGA) Institute. Compared with their siblings, cancer ... of the upper GI tract, lower GI tract ...
... 4 (HealthDay News) -- Vigorous exercise offers more of ... study finds. U.K. researchers compared 11 sedentary people ... assessed before, during, immediately following, and 20 minutes after ... more negative during and immediately after high-intensity exercise, compared ...
Cached Medicine News:Health News:Sonography complements physical exam in identifying juvenile inflammatory arthritis in children 2Health News:Asthma Pills Work as Well as Inhaled Steroids: Study 2Health News:Asthma Pills Work as Well as Inhaled Steroids: Study 3Health News:New Gene Linked to Congenital Heart Defects 2Health News:Grant funds next phase in bringing healthier sorghum closer to underserved communities 2Health News:Childhood cancer survivors are at increased risk for ongoing post-therapy GI complications 2
... Laboratories Platelia Aspergillus EIA is a one-stage ... monoclonal antibody EBA-2 to detect circulating galactomannan ... 3 hours. , ,When used in conjunction ... is an aid in the diagnosis of ...
... The GreenLight PV Laser System ... the Prostate) Procedure for the ... (BPH) allows the urologist to ... a TURP with the safety ...
... diagnosis is generally confirmed by a positive heterophil ... however, is not indicated by the heterophil antibody ... - 20 percent of children. Detection and ... fully ascertain the stage of EBV infection. ...
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
Medicine Products: